期刊文献+

氢氯噻嗪-β-环糊精包合物的制备 被引量:3

Preparation of Inclusion Complex of Hydrochlorothiazide-β-cyclodextrin
原文传递
导出
摘要 目的:制备能提高氢氯噻嗪溶解度的β-环糊精包合物。方法:用共沉淀法及超声法制备氢氯噻嗪-β-环糊精包合物,并经红外光谱法和显微镜观察法鉴定;用紫外分光光度法测定包合物含量及溶解度。结果:用2种制备方法均能形成氢氯噻嗪包合物,其中含量均为20%左右;氢氯噻嗪原料及其物理混合物、共沉淀包合物、超声包合物的溶解度分别为5.65、10.92、106.57、108.72μg·mL-1。结论:氢氯噻嗪与β-环糊精形成包合物后可以显著增加其溶解度。 OBJECTIVE: To prepare hydrochlorothiazide-β-cyclodextrin inclusion complex (HCIC) which can enhance the dissolubility of hydrochlorothiazide. METHODS: The HCIC was prepared by coprecipitation method and ultrasonic method, and which was identified by infrared spectroscopy (IR) and microscopy. The content and dissolubility of the inclusion compound were determined by UV- spectrophotometry. RESULTS: The inclusion complex were successfully formed by the any of the above two technologies with contents all at about 20%. The dissolubilities of hydrochlorothiazide and its physical mixture, the inclusion complex by coprecipitation or ultrasonic method were 5.65, 10.92, 106.57, and 108.72μg · mL^-1, respectively. CONCLUSION: The dissolubility of the hydrochlorothiazide in inclusion complex could be markedly enhanced.
出处 《中国药房》 CAS CSCD 北大核心 2008年第25期1963-1965,共3页 China Pharmacy
关键词 氢氯噻嗪 Β-环糊精包合物 含量测定 溶解度 Hydrochlorothiazide β - cyclodextrin inclusion complex Determination of content Dissolubility
  • 相关文献

参考文献4

二级参考文献5

  • 1陈新谦 金有豫主编.新编药物学.第15版[M].北京:人民卫生出版社,2000.109~110.
  • 2陆彬.药物新制剂与新技术[M].北京:人民卫生出版社,2000.34-36.
  • 3SHIJS RENB MAQJ etal.Lidan rongshi capsule on treating cholelithiasis in 880 cases[J].陕西中医,1999,20(2):49-50.
  • 4WANG Z M.Current Structured Drugs(当代结构药物全集)[M].Beijing Science & Technology Press,1993:1753-1753.
  • 5刘夺奎,董振礼.环糊精包合客体分子机理的研究[J].染料与染色,2004,41(3):155-157. 被引量:20

共引文献14

同被引文献12

  • 1易军,庞小雄,汤佩莲,陈发芸.川芎配方颗粒剂的制备工艺研究[J].广东药学,2005,15(2):49-51. 被引量:3
  • 2冉懋雄,周厚琼.药剂辅料与新药开发[J].中国药房,1996,7(2):53-56. 被引量:6
  • 3崔福德.药剂学[M].第5版.北京:人民卫生出版社,2005:298-299.
  • 4ZAKERI-MILANI P,VALIZADEH H,TAJERZADEH H,et al. Predicting human intestinal permeability using single-pass intestinal perfusion in rat [ J ]. J Pharm Pharm Sci ,2007,10 (3) :368 - 379.
  • 5VENKATESH G, RAMANATHAN S,NAIR NK,et al. Permeability of atenolol and propranolol in the presence of dimethyl sulfoxide in rat single-pass intestinal perfusion assay with liquid chromatog- raphy/UV detection [ J ]. Biomed Chromatogr, 2007, 21 ( 5 ) : 484 - 490.
  • 6SUTTON SC,RINALDI MTS, VUKOVINSKY KE. Comparison of the gravimetric, phenol red, and 14 C-PEG-3350 methods to determine water absorption in the rat single-pass intestinal perfusion model[J]. AAPS Pharm Sci,2001,3(3):25.
  • 7GONZLEZ-GAITANO G, GUERRERO-MARTNEZ A, NEZ-BARRIOCANAL JL,et al. Spectroscopic characterization of the system 15-cyclodextrin + propafenone hydrochloride + water [ J ]. J Phys Chem B,2002,106 (23) :6096 - 6103.
  • 8陆斌.药物新技术与新剂型[M].第2版.北京:人民卫生出版社,2005:40.
  • 9徐叔云,卞如濂.药理实验方法学[M].北京:人民卫生出版社,2006:1758-1762.
  • 10徐新元.应用红外差谱技术鉴定药物包合物及复方制剂中主要成分[J].药物分析杂志,1997,17(2):87-89. 被引量:4

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部